Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingavirin for Influenza and ARVI in Adolescents
NCT03206346Phase 3Completed
- Sponsor
- Valenta Pharm
- Start
- Jan 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Ingavirin in influenza, acute respiratory viral infection (ARVI), sponsored by Valenta Pharm. Started Jan 2012; status: completed.
02
Drugs
Ingavirin
03
Conditions
influenzaacute respiratory viral infection (ARVI)
Beyond the preview
Go deeper on NCT03206346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03206346.